ArticleBlood advances2023
Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase.
Takeshi Harada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleBlood advances2023
Takeshi Harada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.